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level and self-perceived health status. METHODS: An international protocol was 
piloted in the US and Canada. Respondents completed 10 DCE tasks, selecting 
the preferred health state in each paired comparison. Conditional logit 
regression was used to model the discrete choice data. The coefficients were 
compared between the two countries and between the subgroups. RESULTS: 
Models comparing US (n=417) and Canadian-based respondents (n=547) 
estimated similar coefficients that were logically consistent across the 5 levels of 
each dimension of health, except for extreme problems with mobility (US vs 
Canada, -2.00 vs -1.57, p<0.01), and severe problems with self-care (US vs 
Canada, -0.80 vs -1.04, p<0.05). In the US, those <45 years old had worse rating on 
slight problems with mobility or usual activities. All coefficients for problems 
with mobility were lower for males than females. Severe or extreme problems 
with anxiety/depression were assigned lower values among Whites compared to 
Blacks; higher education was associated with lower values for health states with 
severe or extreme problems with pain/discomfort and anxiety/depression. Self-
rated health was not associated with differences in preferences (based on VAS 
<=80, >80). CONCLUSIONS: The DCE-based approach produced different 
preference-based algorithms in the US and Canada. Among US respondents, age, 
gender, race, and educational level are factors that impacted health preferences. 
Study limitations include lack of adjustment for multiple factors in models and 
the need to better understand whether differences in coefficients represent 
meaningful differences.  
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OBJECTIVES: The Asthma Control Questionnaire (ACQ) was developed and 
validated to measure the adequacy of asthma control in patients 11-70 years. 
Younger children have difficulty reading and understanding the instructions, 
questions and response options. For 6-10 year olds, an interviewer version (ACQ-
IA), with instructions on explaining the time specification and interval scale, was 
developed and validated in UK English. If a child has difficulty understanding an 
ACQ question, standardised alternative wording is used. The objective was to 
develop the ACQ-IA in Spanish for Guatemala and Peru, languages in which the 
adult ACQ already exists, using the methodology developed for the UK ACQ-IA. 
METHODS: In each language, the following methodology was used: 1) Forward 
and backward translation of the UK ACQ-IA instructions; 2) Cognitive debriefing 
with children (n=5) to test the instructions and to identify ACQ questions that 
were difficult to comprehend; 3) Development of alternative questions in the 
new language; 4) Developer’s review; 5) Testing of the alternatives on another 
sample of children (n=5); and 6) Developer’s review. RESULTS: In both languages, 
items 1, 2, 3 and 6 required the development of alternatives, because of 
difficulties in understanding words such as “asma” (asthma), “intensos” (strong), 
or actividades (activities). In both languages, the wording of the adult version of 
item 4 (“…how much shortness of breath did you experience because of your 
asthma?”) was well understood and did not require the development of 
alternative wording. Item 5 (“…how much time did you wheeze?”) was 
problematic in Peru, but not in Guatemala. Children had difficulties with 
‘wheeze’ (“te ha silbado el pecho”). The wording used by mothers, “te ha sonado 
el pecho” was more easily understood by children. CONCLUSIONS: The validity 
of this novel methodology for the cultural adaptation ACQ-IA has been further 
supported by these successful adaptations for Peru and Guatemala.  
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OBJECTIVES: The purpose of this study was to explore the impact of fatigue on 
patients with iron deficiency anemia (IDA) and to evaluate patients’ 
understanding and interpretation of the FACIT-Fatigue scale in this patient 
population. Specifically, qualitative interviews with IDA patients were conducted 
to identify concepts associated with fatigue and their impact on patients, and to 
assess the content validity of the FACIT-Fatigue scale. METHODS: The study was 
a two-stage cross-sectional qualitative study that used a non-probabilistic 
purposive sampling strategy. Study participants were recruited across three US 
clinical sites. In-depth one-on-one concept elicitation/ cognitive interviews were 
conducted over the telephone. In the initial concept elicitation portion of the 
interview, patients were asked to talk about their experiences with IDA in 
general before focusing more specifically on fatigue and other disease-related 
symptoms. The cognitive portion of the interview assessed the content of the 
FACIT-Fatigue and patients’ interpretation and understanding of the scale’s 
items, response options, instructions, and recall period. RESULTS: Fifteen IDA 
patients were interviewed. The sample included a wide age range (mean 41.7; 
range 29–73), but included predominantly female patients (93.3%). Analysis of the 
concept elicitation data found that patients spontaneously reported their main 
IDA symptoms to be fatigue (N=8), tiredness (N=13), and low energy (N=8). 
Analysis of the cognitive interview data indicated that all 15 patients were able 
to interpret and understand the majority of the items on the FACIT-Fatigue, and 
felt that the items were relevant to their experience with IDA. CONCLUSIONS: 
The results of the concept elicitation and cognitive debrief interviews support 
the content validity of the FACIT-Fatigue scale within an IDA-specific patient 
population. The scale was confirmed to be meaningful, interpretable, and 
appropriate for use in an IDA patient population.  
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BACKGROUND: Numerous studies have shown that non-adherence to 
medication is associated with increased hospitalization, progression of disease, 
and higher mortality. One of the most common reasons cited for non-adherence 
is patient forgetfulness. Automated telephonic reminders are a cost-effective 
approach to help patients refill their medications on time. OBJECTIVES: To 
evaluate the impact of an automated telephonic reminder system on patients’ 
on-time maintenance medications refills. METHODS: This randomized study 
used claims data from a large pharmacy chain. Patients were randomly assigned 
to an intervention group that received automated telephonic reminders 3 days 
before the expected refill date and a control group that received no calls. For the 
month of February 2012, there were 4,153,634 patients in the intervention group 
who received automated telephonic refill reminder calls for their 7,458,213 
maintenance prescriptions due for refills; the control group had 84,187 patients 
with 148,923 maintenance prescriptions due for refills. On-time refills were 
measured using both daily and cumulative refill rates defined as the percentage 
of prescriptions refilled on or by a specific date around the expected refill date. 
Daily and cumulative refill rates were compared between the intervention and 
control groups to measure the effects of automated telephonic reminders. 
RESULTS: Patients in the intervention group were more likely to refill their 
medications before or on the expected refill date than the control group (26.41% 
vs. 21.85%, p-value<0.001). The effect of telephonic reminders was most 
pronounced 1 or 2 days after the calls. When compared to the control group, 
patients in the intervention group refilled 2.18% and 1.36% more prescriptions 
within 1 and 2 days, respectively, after the call. CONCLUSIONS: Automated 
telephonic reminders helped patients refill their maintenance medications on 
time to ensure continuous supply of medications.  
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OBJECTIVES: Little is known about the equivalence of Web and IVRS survey 
responses. Given the potential to affect power in clinical trials, the purpose of 
this study was to assess the equivalence of PRO survey responses across modes 
(Web, IVRS, and Paper). METHODS: Post-operative colorectal cancer patients at 
Memorial Sloan-Kettering Cancer Center (MSKCC) with home web/email and 
phone were recruited from clinic and randomized to one of eight study groups: 
Groups 1-6 completed the survey via Web, IVRS, and Paper, in one of six possible 
orders; Groups 7-8 completed the survey twice, either by Web or by IVRS. The 
survey contained the 18-item Likert scale MSKCC Bowel Function Instrument 
(BFI) and single-item 11-point NRS LASA QOL. Surveys were completed from 
home, on consecutive days. Mode equivalence was assessed by comparison of 
means across modes and intra-class correlation coefficients (ICC), and was 
compared to the test-retest reliability of Web and IVRS. RESULTS: Of 170 patients 
enrolled, 157 completed at least one survey and were included in analysis. 
Patient sample (N=157) was mean age 56 (SD=11), 53% male, 81% white, 53% 
colon and 47% rectal cancer; 78% completed all assigned surveys. Mean scores 
for BFI total score, BFI subscale scores, and LASA QOL varied by mode by less 
than half a point. ICCs across mode were: BFI total score (Web-Paper=0.96, Web-
IVRS=0.97, Paper-IVRS=0.97); BFI subscales (range=0.88–0.98); and LASA QOL 
(Web-Paper=0.98, Web-IVRS=0.78, Paper-IVRS=0.80). ICCs within mode (test-
retest reliability) were: BFI total score (Web=0.97, IVRS=0.95); BFI subscales 
(range=0.73 – 0.95); and LASA QOL (Web=0.99, IVRS=0.49). CONCLUSIONS: Mode 
equivalence for multiple-item scales was high (>0.88), and for single-item LASA 
QOL > 0.78, and is comparable to test-retest reliability. Whether collecting PRO 
data through one or multiple modes, to adequately power PRO endpoints, 
clinical trialists may increase sample size to account for observed measurement 
reliability.  
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OBJECTIVES: To review and analyze health utility estimates across different 
cardiovascular events and procedures in published cost-utility analyses (CUAs). 
METHODS: We identified CUAs pertaining to cardiovascular diseases published 
between 2000-2010 using the Tufts Medical Center Cost-Effectiveness Analysis 
(CEA) Registry, which contains detailed information on over 3,100 English-
language CUAs with more than 11,500 utility weights. We reviewed the utility 
weights related to cardiovascular disease and classified utilities into nine 
categories: myocardial infarction (MI), heart failure, coronary artery bypass graft 
(CABG) surgery, percutaneous coronary intervention (PCI), stroke, cardiac arrest, 
resuscitated cardiac arrest, peripheral vascular disease (PVD), and transient 
ischemic attack (TIA). RESULTS: We identified 349 cost-utility studies containing 
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1200 utility weights associated with cardiovascular events and procedures. 
Stroke accounted for one-third of total identified cardiovascular utilities, 
followed by myocardial infarction (25%), heart failure (17%), and peripheral 
vascular disease (8%). Most (86%) of the utility estimates were derived from 
secondary references (e.g., published literature). Over one-third (36%) of utilities 
identified were elicited using EQ-5D and 14% were estimated with direct time 
trade-off questions. Among the utilities from published studies disclosing 
sample population information, nearly two-thirds (64%) were elicited from 
patients and 25 % from community members. Few studies (n=27 CUAs, 168 utility 
weights) reported utilities for asymptomatic or symptomatic states prior to the 
cardiovascular event or procedure. CONCLUSIONS: Heterogeneity exists in the 
reporting of cardiovascular utility weights. Analysts conducting CUAs using 
secondary references can improve study transparency by reporting relevant 
utility information, such as sample population, sample size, and assessment 
method. In order to better understand the cost-effectiveness of interventions for 
cardiovascular conditions, further research is needed to inform baseline utility 
measurement prior to cardiovascular events or procedures.  
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OBJECTIVES: Evaluate the psychometric properties of the revised version of the 
Medical Outcomes Study Cognitive Functioning Scale (MOS-Cog-R) using data 
from a representative sample of U.S. adults. METHODS: The 6-item MOS-Cog 
yields a single score representing impairment across a range of cognitive 
functions, including memory, reasoning, attention/concentration, and confusion, 
over the previous four weeks. The MOS-Cog-R introduced several changes: one 
response option was removed; a one-week recall period form was introduced; 
and 0-100 scoring was replaced by norm-based T-scores (mean=50, standard 
deviation=10), standardized using data from a 2009 U.S. internet-based general 
population normative survey to improve interpretability. The psychometric 
properties of both one-week (acute) and four-week (standard) recall forms of the 
MOS-Cog-R were examined within the development sample. Scale reliability was 
evaluated using inter-item correlations and Cronbach’s alpha. Construct validity 
was tested using correlations with relevant continuous criterion variables and 
analysis of covariance models comparing mean MOS-Cog-R scores across levels 
of categorical criterion variables. RESULTS: Acute and standard forms of the 
MOS-Cog-R were completed by 2012 and 2003 respondents, respectively. Both 
forms showed adequate internal consistency reliability (all inter-item 
correlations>0.40; both Cronbach's alphas≥0.89). MOS-Cog-R scores showed 
greater correspondence with mental domains of quality of life than physical 
domains (e.g., correlations for both forms with SF-12v2 mental and physical 
summary scores were ≥0.55 and ≤0.28, respectively). Direction and magnitude of 
correlations with criterion measures of psychological status (e.g., depression, 
anxiety) and health outcomes indicated good convergent validity for both forms. 
Differences in mean scores across respondents stratified by criterion outcomes 
supported adequate discriminant validity of each form. CONCLUSIONS: The 
MOS-Cog-R introduces a number of improvements, including simplified 
responses, the introduction of a one-week recall form, and norm-based scoring 
that enhances interpretability of scores. Both acute and standard recall-period 
forms of the MOS-Cog-R demonstrated good reliability and validity.  
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OBJECTIVES: To establish an EQ-5D-3L value set using time trade-off (TTO) 
values directly measured from the general Singaporean population. METHODS: 
The values of 80 EQ-5D-3L health states were directly elicited from a general 
Singaporean population sample using a TTO method modified from the MVH 
protocol. In face-to-face interviews, participants were asked to value a block of 
10 health states. Various linear regression models and model specifications were 
examined to assess their goodness of fit to the data, at both individual and 
aggregated levels, and ability to predict the values for measured and 
unmeasured EQ-5D-3L health states. Goodness of fit was assessed in terms of 
mean absolute error (MAE), numbers of prediction errors larger than 0.05 and 
0.10; while prediction ability was assessed in terms of logic consistency and bias. 
RESULTS: A total of 500 participants provided data for this study. The N3 model 
without a constant using the random-effects estimator exhibited the best fit of 
the data at individual level, predicted values with the least bias, and generated 
logically consistent values for all 243 EQ-5D-5L health states. The MAE was 
0.1227, and 41 out of 80 predicted values had errors less than 0.10 in absolute 
magnitude. Based on this model, the second highest utility value is 0.8867 for 
state 21,111and the lowest value is -0.7284 for state 33,333. CONCLUSIONS: This 
study established the value set of EQ-5D-3L health states for Singapore. The 
value set provides health services researchers in Singapore a useful tool for 
assessing the cost-effectiveness of health technologies and services.  
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OBJECTIVES: The Provider-Dependent Health Care Orientation (PDHCO; Kaplan 
1996) assesses an individual’s orientation towards health and health care and 
measures an individual’s dependence (i.e., passivity) related to health care and 
disease management. We sought to build on prior validation of the instrument 
by evaluating the reproducibility of the PDHCO and testing equivalence between 
paper and electronic administration modes. METHODS: The PDHCO and other 
questionnaires were administered to a sample of adults recruited through web-
based advertisements in 8 U.S. cities. Participants completed the PDHCO on 
paper and computerized formats in a randomized crossover design. A one-week 
retest was completed at home. Reproducibility and mode equivalence were 
assessed using the intraclass correlation coefficient (ICC). Cronbach’s alpha was 
calculated to assess internal consistency. To assess convergent validity, the 
correlation of the PDHCO to the Communication With Physician (CWP) Scale of 
the Chronic Disease Self-Efficacy Scale was calculated. ANOVA was used to 
compare mean PDHCO scores among tertiles of the Health Assertiveness Scale 
(HAS). RESULTS: Of the 230 participants that completed baseline assessment, 228 
(99.1%) completed the one-week retest. The mean age of participants was 44.3 
years, 51.3% were female, and 58.3% were Caucasian. A small number (n=9; 3.9%) 
reported their health as Poor. The mean PDHCO score was 49.7(±14.7), and the 
ICC between paper and computerized administration was 0.887. The ICC for the 
one-week retest of the paper format was 0.913, and the PDHCO was found to be 
internally consistent (Cronbach’s alpha=0.735). Significant correlations were 
found with the CWP (r=-0.246; p<.001), and the instrument discriminated 
between levels of the HAS (p<0.05). CONCLUSIONS: The PDHCO was observed to 
have adequate reproducibility and internal consistency as well as appropriate 
convergent validity. The scale was found to significantly discriminate between 
levels of health assertiveness. Equivalence between paper and web-based 
administration was demonstrated.  
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OBJECTIVES: In the absence of any pulmonary arterial hypertension (PAH)-
specific PRO instruments developed in accordance with 2009 FDA guidance 
requirements, this qualitative research study was conducted to develop a new 
instrument assessing PAH symptoms and their impacts following the PRO 
guidance. METHODS: Patient inclusion criteria were age 18–80 years and 
symptomatic PAH (WHO Group 1) diagnosed by right-heart catheterization. 
Concept elicitation was based on 5 focus groups, after which saturation of 
emergent concepts was reached. A PRO instrument for PAH symptoms and their 
impacts was drafted, considering input from the international Steering 
Committee as well as translatability and legibility assessments. Two rounds of 
cognitive interviews on the draft PRO were conducted, with instrument revisions 
following each. The study was approved by institutional review boards at 5 US 
sites and participants provided written informed consent. RESULTS: Focus 
groups comprised 25 patients, and 20 additional patients participated in 
cognitive interviews (10 per round). Participants had a mean±SD age of 54±16 
years, were predominantly female (91%), and were diverse in race/ethnicity, 
WHO functional class (FC I/II: 51%, III/IV: 49%), and etiology (associated PAH: 51%, 
idiopathic PAH: 47%, familial PAH: 2%). The draft PRO instrument was found to 
be clear, comprehensive, and relevant to PAH patients in cognitive interviews. 
Items were organized in a draft conceptual framework with 4 symptom domains 
(respiratory symptoms, tiredness, cardiovascular symptoms, other symptoms) 
and 5 impact domains (physical activities, daily activities, social impact, 
cognition, emotional impact). The recall period is the past 24 hours for symptom 
items, and 7 days for impact items. CONCLUSIONS: The draft instrument was 
shown to capture symptoms and their impacts relevant to PAH patients, 
demonstrating content saturation and concept validity. Additional testing is 
needed to confirm the content and psychometric validity of the PAH-SYMPACT 
before use in future clinical practice or studies.  
 
PRM121  
USING A LIFE SATISFACTION MEASURE IN THE VALUATION OF HEALTH: A 
CASE STUDY OF MULTIPLE SCLEROSIS  
Suponcic S, DiBonaventura M, Kopenhafer L 
Kantar Health, New York, NY, USA  
OBJECTIVES: The valuation of health is becoming increasingly important for the 
purposes of health technology assessment. However, recent research has 
suggested that traditional preference-based measures for valuing health states 
may be flawed and life satisfaction measures may better represent the patient 
perspective. The current study extended this research by examining the validity 
of a life satisfaction measure among patients with multiple sclerosis (MS). 
METHODS: Data from the Multiple Sclerosis Patient study (N=1000) were used, 
which were collected from an Internet-based survey of patients who self-
reported a diagnosis of MS. Information on demographics, disease and treatment 
history, and health outcomes were collected. A life satisfaction measure was 
included (1=not satisfied to 7=completely satisfied) and examined alongside MS-
specific symptom and quality of life measures. RESULTS: Respondents were 
mostly female (82.8%) with an average age of 48.7 years. Most respondents had 
relapsing remitting MS (89.0%). The mean life satisfaction scores were 4.87 
(SD=1.26; IQR:4-6). Only small effects were observed between life satisfaction and 
